Journal of Affective Disorders
Volume 110, Issue 1 , Pages 126-134 , September 2008

Going up in smoke: Tobacco smoking is associated with worse treatment outcomes in mania

  • Michael Berk

      Affiliations

    • University of Melbourne, Victoria, Australia
    • Barwon Health and The Geelong Clinic, Australia
    • ORYGEN Research Centre, Parkville, Australia
    • Mental Health Research Institute, Parkville, Australia
    • ,
  • Felicity Ng

      Affiliations

    • University of Melbourne, Victoria, Australia
    • Barwon Health and The Geelong Clinic, Australia
    • Corresponding Author InformationCorresponding author. Department of Clinical and Biomedical Sciences: Barwon Health, University of Melbourne, Swanston Centre, PO Box 281, Geelong, Victoria 3220, Australia. Tel.: +61 3 5260 3143; fax: +61 3 5246 5165.
    • ,
  • Wei V. Wang

      Affiliations

    • Lilly Research Laboratories Indianapolis IN, USA
    • ,
  • Mauricio Tohen

      Affiliations

    • Lilly Research Laboratories Indianapolis IN, USA
    • McLean Hospital, Harvard Medical School, Belmont MA, USA
    • ,
  • Dan I. Lubman

      Affiliations

    • University of Melbourne, Victoria, Australia
    • ORYGEN Research Centre, Parkville, Australia
    • ,
  • Eduard Vieta

      Affiliations

    • University of Barcelona, Hospital Clinic, IDIBAPS, CIBER-SAM, Spain
    • ,
  • Seetal Dodd

      Affiliations

    • University of Melbourne, Victoria, Australia
    • Barwon Health and The Geelong Clinic, Australia

Received 6 December 2007 ,Revised 16 January 2008 ,Accepted 16 January 2008.

References 

  1. American Psychiatric Association . Practice Guidelines for the Treatment of Patients with Substance Use Disorders. 2nd edition. 2006;http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm access date 27th Feb 2007, 2nd ed.
  2. Berk M, Dodd S, Kauer-Sant'anna M, Malhi GS, Bourin M, Kapczinski F, et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr. Scand. 2007;116:41–49
  3. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking. A longitudinal investigation. Arch. Gen. Psychiatry. 1998;55:161–166
  4. Cassidy F, Mcevoy JP, Yang YK, Wilson WH. Smoking and psychosis in patients with bipolar I disorder. Compr. Psychiatry. 2002;43:63–64
  5. Chandra PS, Carey MP, Carey KB, Jairam KR, Girish NS, Rudresh HP. Prevalence and correlates of tobacco use and nicotine dependence among psychiatric patients in India. Addict. Behav. 2005;30:1290–1299
  6. Choi WS, Patten CA, Gillin JC, Kaplan RM, Pierce JP. Cigarette smoking predicts development of depressive symptoms among U.S. adolescents. Ann. Behav. Med. 1997;19:42–50
  7. Corvin A, O'mahony E, O'regan M, Comerford C, O'connell R, Craddock N, et al. Cigarette smoking and psychotic symptoms in bipolar affective disorder. Br. J. Psychiatry. 2001;179:35–38
  8. Dani JA, De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol. Biochem. Behav. 2001;70:439–446
  9. De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH. Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia. Acta Psychiatr. Scand. 2006;114:211–215
  10. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15:469–494
  11. Diwan A, Castine M, Pomerleau CS, Meador-Woodruff JH, Dalack GW. Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders. Schizophr. Res. 1998;33:113–118
  12. Fagerstrom K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs. 2002;62(Suppl. 2):1–9
  13. Fowler JS, Logan J, Wang GJ, Volkow ND. Monoamine oxidase and cigarette smoking. Neurotoxicology. 2003;24:75–82
  14. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry. 2004;61:1107–1115
  15. Hutchison KE, Rutter MC, Niaura R, Swift RM, Pickworth WB, Sobik L. Olanzapine attenuates cue-elicited craving for tobacco. Psychopharmacology (Berl.). 2004;175:407–413
  16. Johnson EO, Breslau N. Is the association of smoking and depression a recent phenomenon?. Nicotine Tob. Res. 2006;8:257–262
  17. Kendler KS, Neale MC, Maclean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression. A causal analysis. Arch. Gen. Psychiatry. 1993;50:36–43
  18. Klungsoyr O, Nygard JF, Sorensen T, Sandanger I. Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am. J. Epidemiol. 2006;163:421–432
  19. Laviolette SR, Van Der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat. Rev., Neurosci. 2004;5:55–65
  20. Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C, et al. Smoking and mental illness. Pharmacol. Biochem. Behav. 2001;70:561–570
  21. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, et al. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch. Gen. Psychiatry. 2002;59:1085–1096
  22. Malhi GS, Berk M. Does dopamine dysfunction drive depression?. Acta Psychiatr. Scand., Suppl. 2007;116–124
  23. Mallinckrodt CH, Clark SW, Carroll RJ, Molenbergh G. Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations. J. Biopharm. Stat. 2003;13:179–190
  24. Martin LF, Leonard S, Hall MH, Tregellas JR, Freedman R, Olincy A. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am. J. Med. Genet. B., Neuropsychiatr. Genet. 2007;144:611–614
  25. Olivier D, Lubman DI, Fraser R. Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective. Aust. N. Z. J. Psychiatry. 2007;41:572–580
  26. Ostacher MJ, Nierenberg AA, Perlis RH, Eidelman P, Borrelli DJ, Tran TB, et al. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J. Clin. Psychiatry. 2006;67:1907–1911
  27. Tohen M, Sanger TM, Mcelroy SL, Tollefson GD, Chengappa KN, Daniel DG, et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry. 1999;156:702–709
  28. Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, et al. Olanzapine versus divalproex in the treatment of acute mania. Am. J. Psychiatry. 2002;159:1011–1017
  29. Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, et al. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch. Gen. Psychiatry. 2003;60:1218–1226
  30. Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am. J. Psychiatry. 2003;160:1263–1271
  31. Vanable PA, Carey MP, Carey KB, Maisto SA. Smoking among psychiatric outpatients: relationship to substance use, diagnosis, and illness severity. Psychol. Addict. Behav. 2003;17:259–265
  32. Vieta E, Colom F, Corbella B, Martinez-Aran A, Reinares M, Benabarre A, et al. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord. 2001;3:253–258
  33. Waxmonsky JA, Thomas MR, Miklowitz DJ, Allen MH, Wisniewski SR, Zhang H, et al. Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. Gen. Hosp. Psych. 2005;27:321–328
  34. Wu LT, Anthony JC. Tobacco smoking and depressed mood in late childhood and early adolescence. Am. J. Public Health. 1999;89:1837–1840

PII: S0165-0327(08)00038-4

doi: 10.1016/j.jad.2008.01.018

Journal of Affective Disorders
Volume 110, Issue 1 , Pages 126-134 , September 2008

Article Tools

* Image Usage & Resolution